BENGALURU/HYDERABAD (Reuters) - India's Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in key markets such as the United States.
The company reported a consolidated profit after tax of 24.24 billion rupees ($292 million) for the quarter ended Dec. 31, beating analysts' estimate of 24.17 billion rupees as per LSEG data.
($1 = 83.0010 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru and Rishika Sadam in Hyderabad; Editing by Mrigank Dhaniwala and Varun H K)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,507 INR | -0.89% | -1.07% | 43.34B | ||
| 2,686 PTS | +0.86% | +2.29% | - | ||
